[The mechanism of action of hypolipidemic drugs].
Scheen
A J
AJ
Service Associé, Université de Liège.
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism; D000924:Anticholesteremic Agents / Q000494:pharmacology; D008078:Cholesterol, LDL / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005229:Fatty Acids, Monounsaturated / Q000494:pharmacology; D000077340:Fluvastatin; D006801:Humans; D006903:Hydroxymethylglutaryl CoA Reductases / Q000378:metabolism; D006937:Hypercholesterolemia / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000145:classification / Q000494:pharmacology*; D007211:Indoles / Q000494:pharmacology; D008049:Lipase / Q000187:drug effects; D015227:Lipid Peroxidation / Q000187:drug effects; D008079:Lipoproteins, VLDL / Q000037:antagonists & inhibitors; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008148:Lovastatin / Q000031:analogs & derivatives / Q000494:pharmacology; D008830:Microbodies / Q000187:drug effects; D009687:Nuclear Proteins / Q000187:drug effects; D017035:Pravastatin / Q000494:pharmacology; D018160:Receptors, Cytoplasmic and Nuclear / Q000187:drug effects; D011973:Receptors, LDL / Q000187:drug effects; D019821:Simvastatin; D014157:Transcription Factors / Q000187:drug effects
D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D004791:Enzyme Inhibitors; D005229:Fatty Acids, Monounsaturated; D000960:Hypolipidemic Agents; D007211:Indoles; D008079:Lipoproteins, VLDL; D009687:Nuclear Proteins; D018160:Receptors, Cytoplasmic and Nuclear; D011973:Receptors, LDL; D014157:Transcription Factors; D000077340:Fluvastatin; D008148:Lovastatin; D019821:Simvastatin; D006903:Hydroxymethylglutaryl CoA Reductases; D008049:Lipase; D017035:Pravastatin